• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

What is new with your awful company?













It is not that we discriminate.

It is that, once people reach about 35, they realize that the industry is a total scam, and they just can't drink the Kool Aid anymore.